Clinical trial
Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's…
NCT00260793 · Agarwal, Pinky, M.D., Other · Unknown status
Key facts
| NCT number | NCT00260793 |
|---|---|
| Title | Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease |
| Official title | Open Label Prospective Study of High Dose Ropinirole for Motor Fluctuations and Dyskinesias in Advanced Parkinson's Disease |
| Lead sponsor | Agarwal, Pinky, M.D., Other |
| Collaborators | Colorado Neurology GlaxoSmithKline Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Ropinirole Hydrochloride |
| Enrollment | 20 |
| Start date | Nov 1, 2005 |
| First posted | Dec 2, 2005 |
| Last update posted | Feb 3, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: